FindTrial
Sign In

therapeutic immune globulin

BIOLOGICAL3 trials

Sponsors

Temple University, Children's Oncology Group, Institut Paoli-Calmettes

Conditions

Chronic Myeloproliferative DisordersLeukemiaLocalized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases

Phase 2

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
CompletedNCT00002809
Temple UniversityLeukemia, Myelodysplastic/Myeloproliferative Diseases, Myelodysplastic Syndromes
Start: 1996-08-31End: 2003-12-31Target: 10Updated: 2010-10-01
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
CompletedNCT00806767
Institut Paoli-CalmettesChronic Myeloproliferative Disorders, Leukemia, Lymphoma +3
Start: 2007-03-31Target: 82Updated: 2011-05-17

Phase 3

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
CompletedNCT00033293
Children's Oncology GroupLocalized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma +2
Start: 2004-03-15End: 2022-12-31Updated: 2023-04-18

Related Papers

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
2017-11-0337 citations